Oncologists Can Now Offer Patients Hope In Fight Against Pancreatic Cancer
Results of the long-awaited clinical trial of the drug daraxonrasib were presented Sunday at the American Society of Clinical Oncology’s meeting in Chicago. “Unprecedented,” “compelling,” and “spectacular” are some of the words being used to describe the results, The Washington Post reports.
https://kffhealthnews.org/morning-breakout/cancer-3/
No hay comentarios:
Publicar un comentario